Associate Professor, Peking University Peoples’ Hospital, China.
Dr. Fumei Gao is a distinguished Deputy Chief Physician in Obstetrics and Gynecology at Peking University People’s Hospital. With profound expertise in reproductive toxicology and infertility treatment, she integrates clinical practice with molecular research to address reproductive health challenges. Her work spans environmental exposure assessment and fertility treatments, making significant contributions to both clinical and academic fields. ๐ก๐ฉบ
Professional Profile
Scopus
๐ Education
Dr. Gao earned her Bachelorโs degree in Clinical Medicine from Qingdao Medical College, Qingdao University (2003.9 – 2008.7), followed by her Masterโs and M.D. in Obstetrics and Gynecology from Peking University Peopleโs Hospital (2008.9 – 2013.7). Her robust academic foundation underpins her advanced clinical and research pursuits in reproductive health. ๐๐ฌ
๐ผ Experience
Dr. Gao began her career as a Postdoctoral Fellow at the College of Urban and Environmental Sciences, Peking University (2013.7 โ 2015.7). She completed her Residency in Obstetrics and Gynecology at Peking University Peopleโs Hospital (2008.9 – 2013.7 & 2015.7 – 2016.6). She then served as Attending Physician (2016.6 – 2022.8) and is currently a Deputy Chief Physician (2022.8 โ present), focusing on infertility and reproductive toxicology. ๐ฉโโ๏ธ
๐ฌ Research Interests
Her research focuses on the impact of environmental disruptor chemicals on reproductive health, reproductive toxicology mechanisms, infertility treatments, and ovarian stimulation. ๐ She is skilled in molecular biology techniques like qPCR, Western Blot, IHC, and in vivo mouse models, as well as clinical data science and statistical analysis. ๐งช๐
๐ Top Noted Publications
Exposure assessment of aryl-organophosphate esters and reproductive hormone disruption in women
๐ Environment International, 2022
Cited by several studies for its impact on endocrine health.
Screening of Organophosphate Flame Retardants in Placental Models and Mice
๐ Environmental Health Perspectives, 2022
Key reference for placental toxicology research.
Mono-2-ethylhexyl phthalate inhibits trophoblast invasion via PPARฮณ pathway
๐ Toxicology and Applied Pharmacology, 2017
Widely cited in reproductive toxicology research.
Phthalate Metabolites in Pregnancy and Risk of Clinical Pregnancy Loss
๐ Environmental Science & Technology, 2015
Recognized in environmental exposure studies.
Low house cleaning frequency and miscarriage risk in China
๐ International Journal of Environmental Research and Public Health, 2021
Highlighted in lifestyle and reproductive health studies.
Effects of letrozole co-treatment on cumulative live-birth rate in IVF
๐ Frontiers in Medicine, 2022
Frequently referenced in assisted reproductive technology research.
Effect of Dual Trigger in IVF for Women with Diminished Ovarian Reserve
๐ Current Medical Science, 2022
Significant for fertility treatment advancements.
Premature Luteinizing Hormone Rise and Reduced IVF Success in Older Women
๐ Frontiers in Endocrinology, 2021
Cited for IVF cycle optimization in older patients.
Dual Trigger Using GnRH Agonist and hCG in Normal Responders in IVF
๐ Frontiers in Medicine, 2021
Frequently referenced for improving IVF protocols.
Case Reports on Endometriosis-Related Hemoperitoneum in Pregnancy
๐ Chinese Medical Journal, 2018
Important clinical reference for rare obstetric cases.
Conclusion
Dr. Fumei Gao is highly suitable for the Best Researcher Award given her proven research excellence, clinical expertise, and significant contributions to reproductive toxicology and infertility treatments. Her publications, covering high-impact studies on endocrine disruptors and infertility, clearly demonstrate her leadership in this niche field. With continued focus on international networking and translational research, she is poised to make even greater strides in reproductive medicine. She fully meets the merit required for this award.